STAA Stock Analysis: Buy, Sell, or Hold?
STAA - Staar Surgical Co
$18.95
0.01 (0.05%)
β²
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
8d
Get Alerted When STAA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called STAA this week
0% bullish • 2 bearish
0% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
β BUY SIGNAL: STAA trading at deep discount. Market pricing in -7.7% annual earnings decline, creating value opportunity for patient investors.
β BUY SIGNAL: STAA trading at deep discount. Market pricing in -7.7% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.93
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.13
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STAA is currently trading at $18.95, which is considered oversold relative to its 30-day fair value range of $20.42 to $23.77. From a valuation perspective, the stock is trading at a discount (Forward PE: 51.5) compared to its historical average (65.4). Remarkably, the market is currently pricing in an annual earnings decline of 7.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, STAA is in a strong downtrend. The price is currently testing key support at $18.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.36 (+23.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STAA is in a strong downtrend. The price is currently testing key support at $18.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.36 (+23.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$20.42 -
$23.77
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.3% below Wall St target ($23.36)
Fair Price Analysis
30-Day Fair Range
$20.42 -
$23.77
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$18.67
Resistance Level
$21.27
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
51.45
Wall Street Target
$23.36
(+23.3%)
Revenue Growth (YoY)
6.9%
Earnings Growth (YoY)
-10.5%
Profit Margin
-41.8%
Valuation Discount vs History
-7.7% cheaper
PE vs Historical
51.5 vs 65.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.7%
(market-implied from PE analysis)
1-Year Target
$17.49
(-8%)
2-Year Target
$16.14
(-15%)
3-Year Target
$14.90
(-21%)
3-Yr Target (if PE normalizes)
(PE: 51β65)
$18.94
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 51.5, Growth: 2669.2%)
$63.96
(+238%)
Base:
(SPY PE: 22.3, Growth: 2669.2%)
$27.72
(+46%)
Bear:
(PE: 19.0, Growth: 2669.2%)
$23.56
(+24%)
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 51.5 to 65.4
Stabilization Target:
$24.09
(+27.1%)
PE Expansion Potential:
+27.1%
Last updated: February 01, 2026 12:55 AM ET
Data refreshes hourly during market hours. Next update: 1:55 AM
Data refreshes hourly during market hours. Next update: 1:55 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STAA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced STAA Option Strategies
Professional options setups generated by AI based on today's STAA price and gamma walls.